ArticleMolecular therapy. Nucleic acids2026

Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to target

Roxanne Hsiang-Chi Liou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.